Gold prices remain resilient near $4,295 an ounce despite strong selling pressure from rising US bond yields hitting two-decade highs. This is driven by expectations of a Federal Reserve rate hike to combat persistent inflation and geopolitical tensions in the Middle East pushing oil prices higher. Commerzbank notes that gold's relative strength may reflect market hedging against a potential clash between the Fed and the Trump administration, which has pressured the Fed to cut rates. While higher rates typically weigh on gold, the bank expects limited downside this year, forecasting gold around $4,500 an ounce by year-end, supported by skepticism of the US dollar and concerns over sovereign debt risks.
Gold price dynamics amid US interest rate tensions provide context for Pluang's market snapshot as of Sep 16, 2026 00:21 WIB: out of 150 US stocks, 44 rose and 106 fell. Among notable movers, Opendoor Technologies Inc dropped 5.20% to USD 2.65, Sea Limited declined 4.73% to USD 103.53, and Carvana Co fell 4.62% to USD 67.59. This contrasts with gold's resilience near $4,295 an ounce despite rising US bond yields and geopolitical risks.
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Comcast announced a strategic restructuring to separate its connectivity and technology division from its media operations, including NBCUniversal and Sky. UBS raised Comcast's price target to $27, suggesting a 10% upside from current prices. The com...
